Skip to main content
Clinical Trials/NCT04532008
NCT04532008CompletedNot Applicable

The ASHA Project: Pilot Study of a Depression Treatment/Economic Empowerment

Albert Einstein College of Medicine0 sites48 target enrollmentStarted: September 1, 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
48
Primary Endpoint
Depressive Symptoms

Study Overview

Brief Summary

This pilot study randomized 48 depressed rural Bangladeshi housewives to either intervention or control groups. The intervention groups received depression treatment and a financial empowerment intervention.

Detailed Description

This study was conducted in the rural Sirajganj region of Bangladesh. Working with the International Centre for Diarrhoeal Disease Research, Bangladesh and a local NGO, we recruited 48 depressed rural housewives for the study. Participants were randomized into intervention in control groups. The intervention groups (n=24) received 12 sessions of evidence based depression treatment, financial literacy education, agricultural training and skill building. They opened bank accounts and saved for six months. At the end of the six month period, participants who had met savings and attendance requirements received a cash transfer of approximately $186, which was used to purchase a productive asset. 22 participants purchased an agricultural animal, usually a goat; 1 financed a small retail business, and 1 leased land to grow crops for sale. Depression scores on the PHD-9 were sharply reduced. The study had 100% retention.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18-40
  • PHQ greater than 10
  • Able to save
  • Able to read and write

Exclusion Criteria

  • Not in age range PhQ below 10 Unable to contribute to savings account Illiterate

Outcomes

Primary Outcomes

Depressive Symptoms

Time Frame: 12 months post baseline

symptoms on the Patient Health Questionnaire (PHD-9), ranging from 0 to 27, with higher scores indicating worse outcomes

Secondary Outcomes

  • Retention(Assessed at 12 Months post basline)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Alison Karasz

Associate Professor

Albert Einstein College of Medicine

Similar Trials